Journal
CELL HOST & MICROBE
Volume 14, Issue 1, Pages 104-115Publisher
CELL PRESS
DOI: 10.1016/j.chom.2013.06.005
Keywords
-
Categories
Funding
- Phase II NIAID, NIH Small Business Innovative Research Grant [2R44A1055229]
- NIH [R01GM089652]
- Bill & Melinda Gates Foundation [51066]
- Agency for Science, Technology and Research (A*STAR, Singapore) NSS
- Medicines for Malaria Venture
Ask authors/readers for more resources
The Plasmodium liver stage is an attractive target for the development of antimalarial drugs and vaccines, as it provides an opportunity to interrupt the life cycle of the parasite at a critical early stage. However, targeting the liver stage has been difficult. Undoubtedly, a major barrier has been the lack of robust, reliable, and reproducible in vitro liver-stage cultures. Here, we establish the liver stages for both Plasmodium falciparum and Plasmodium vivax in a microscale human liver platform composed of cryopreserved, micropatterned human primary hepatocytes surrounded by supportive stromal cells. Using this system, we have successfully recapitulated the full liver stage of P. falciparum, including the release of infected merozoites and infection of overlaid erythrocytes, as well as the establishment of small forms in late liver stages of P. vivax. Finally, we validate the potential of this platform as a tool for medium-throughput antimalarial drug screening and vaccine development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available